The Issue of Monocyte Activation in ASD: Troubles with Translation

Area of Science:

• Immunology
• Neurodevelopmental Disorders
• Genetics

Background:

• Autism spectrum disorder (ASD) prevalence is rising, with immune system dysregulation implicated in its pathology.
• Both innate and adaptive immune responses, including monocytes and microglia, show evidence of dysregulation in ASD.
• Previous research suggests an orchestrated innate immune response may play a role in ASD development.

Purpose of the Study:

• To investigate transcriptome differences in monocytes from children with ASD compared to typically developing children.
• To identify specific gene expression patterns and activation pathways altered in ASD monocytes.
• To explore the potential mechanistic link between monocyte dysfunction and ASD.

Main Methods:

• Utilized next-generation bulk-RNA sequencing on isolated CD14+ monocytes.
• Analyzed monocytes from children with autistic disorder (AD) and pervasive developmental disorder not otherwise specified (PDD-NOS).
• Compared gene expression and activation pathways after Toll-like receptor agonist stimulation against typically developing controls.

Main Results:

• Monocytes from children with ASD and PDD-NOS showed upregulated translational machinery compared to controls.
• Gene enrichment analysis revealed differences in activation pathways between neurodevelopmental disorder groups and controls.
• Several differentially expressed genes in ASD monocytes are known ASD risk genes or associated with inflammatory bowel disease.

Conclusions:

• Altered monocyte activation and a lack of regulatory control may be a mechanistic factor in ASD.
• Findings implicate immune system dysregulation, specifically in monocytes, as a potential contributor to ASD.
• Further research is needed to understand the specific monocyte regulatory mechanisms that differ in individuals with ASD.